Infliximab Biologic Therapy: What to Know

Infliximab is a monoclonal antibody that blocks tumour necrosis factor, a chemical messenger that can sustain inflammation. It is given through a vein at a clinic, so the team can observe you during and after the infusion. The schedule and suitability depend on the condition, previous treatments, infection history, and overall health.

Dermatologists may discuss biologic therapy for difficult inflammatory disease such as Psoriasis or selected Hidradenitis Suppurativa. Nail Psoriasis may be part of the assessment when skin and nail symptoms occur together. Infliximab is different from Adalimumab, although both target the same inflammatory messenger.

Tell the treating team about fever, cough, recent infections, tuberculosis exposure, liver disease, heart problems, allergies, pregnancy plans, and every medicine or supplement you take. Screening and blood tests may be arranged before treatment and repeated during follow-up. Do not start, stop, or delay infusions without contacting the prescribing team.

During an infusion, report itching, flushing, chest tightness, dizziness, breathing trouble, or feeling faint immediately. Afterward, watch for infection symptoms and keep scheduled reviews. Your clinician may compare infliximab with Biologic Therapy options or Methotrexate Treatment when planning care.

Contact your medical team promptly for persistent fever, worsening cough, painful urination, unusual wounds, severe fatigue, or new neurological symptoms. Seek emergency care for trouble breathing, facial swelling, severe chest symptoms, or confusion. An infection may need assessment before the next infusion.

Ask why infliximab is being considered, what screening is needed, how infusions are scheduled, which vaccines or medicines require planning, and how response or side effects will be followed.